Literature DB >> 8128939

A prospective comparison of methods for determining if cardiovascular disease is a predictor of mortality in dialysis patients.

M A Farias1, W McClellan, J M Soucie, W E Mitch.   

Abstract

A random sample of 464 dialysis patients was surveyed between December 1990 and June 1991 to compare methods for determining the relationship between cardiovascular disease (CVD) and mortality. The following three methods were used to identify the prevalence of CVD: standard epidemiologic questionnaires, recall by the patient, and a review of the medical record. The 1-year mortality rate during this prospective study (average follow-up, 17.5 months) was 19%. The measure of prevalent CVD found to be the best predictor of the risk of mortality was the review of the medical record. Specifically, after controlling for the effects on mortality of age, sex, race, cause of renal failure, serum albumin level, and performance status (determined by the Karnofsky score), a patient with a history of angina pectoris documented in the medical record had a relative risk (95% confidence interval) of mortality of 1.8 (1.1 to 2.8), and a patient with peripheral vascular disease recorded in the medical record had a relative risk of 1.6 (1.0 to 2.4). Estimates of CVD obtained from either the questionnaires or patient recall resulted in associations between CVD and mortality that were substantially weaker than those for the medical record. We conclude that at present the medical record is the best source of information for estimating the presence of CVD as a mortality risk factor in dialysis patients. We recommend inclusion of a medical record history of CVD as a mortality case-mix factor when comparing dialysis populations.

Entities:  

Mesh:

Year:  1994        PMID: 8128939     DOI: 10.1016/s0272-6386(12)81000-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

1.  Coronary Angiography Profile at the Time of Hemodialysis Initiation in End-Stage Renal Disease Population: A Retrospective Analysis.

Authors:  M Surendra; S Raju; K K Mukku; C H Ved Prakash; N Raju
Journal:  Indian J Nephrol       Date:  2018 Sep-Oct

2.  Clinical utility of myocardial fatty acid imaging in patients with end-stage renal disease.

Authors:  Masato Nishimura; Toshihiko Ono
Journal:  J Nucl Cardiol       Date:  2008-09-16       Impact factor: 5.952

3.  A more appropriate cardiac troponin T level that can predict outcomes in end-stage renal disease patients with acute coronary syndrome.

Authors:  Dong-Ryeol Ryu; Jung Tak Park; Jung Hwa Chung; Eun Mi Song; Sun Hee Roh; Jeong-Min Lee; Hye Rim An; Mina Yu; Wook Bum Pyun; Gil Ja Shin; Seung-Jung Kim; Duk-Hee Kang; Kyu Bok Choi
Journal:  Yonsei Med J       Date:  2011-07       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.